185 related articles for article (PubMed ID: 17672906)
1. Validation of two generic patient-reported outcome measures in patients with type 2 diabetes.
Matza LS; Boye KS; Yurgin N
Health Qual Life Outcomes; 2007 Jul; 5():47. PubMed ID: 17672906
[TBL] [Abstract][Full Text] [Related]
2. Validity and reliability of the EQ-5D-3L (a generic preference-based instrument used for calculating quality-adjusted life -years) for patients with type 2 diabetes in Iran.
Zare F; Ameri H; Madadizadeh F; Aghaei MR
Diabetes Metab Syndr; 2021; 15(1):319-324. PubMed ID: 33486224
[TBL] [Abstract][Full Text] [Related]
3. Assessing the reliability and validity of the ICECAP-A instrument in Chinese type 2 diabetes patients.
Xiong Y; Wu H; Xu J
Health Qual Life Outcomes; 2021 Jan; 19(1):5. PubMed ID: 33407525
[TBL] [Abstract][Full Text] [Related]
4. A review of the psychometric properties of generic utility measures in multiple sclerosis.
Kuspinar A; Mayo NE
Pharmacoeconomics; 2014 Aug; 32(8):759-73. PubMed ID: 24846760
[TBL] [Abstract][Full Text] [Related]
5. Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare?
Feng Y; Devlin N; Herdman M
Health Qual Life Outcomes; 2015 Oct; 13():171. PubMed ID: 26489956
[TBL] [Abstract][Full Text] [Related]
6. Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy.
Bhadhuri A; Kind P; Salari P; Jungo KT; Boland B; Byrne S; Hossmann S; Dalleur O; Knol W; Moutzouri E; O'Mahony D; Murphy KD; Wisselink L; Rodondi N; Schwenkglenks M
Health Qual Life Outcomes; 2020 Sep; 18(1):317. PubMed ID: 32993637
[TBL] [Abstract][Full Text] [Related]
7. Performance of the EQ-5D in patients with irritable bowel syndrome.
Bushnell DM; Martin ML; Ricci JF; Bracco A
Value Health; 2006; 9(2):90-7. PubMed ID: 16626412
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the construct validity and responsiveness of preference-based quality of life measures in people with Parkinson's: a systematic review.
Xin Y; McIntosh E
Qual Life Res; 2017 Jan; 26(1):1-23. PubMed ID: 27778141
[TBL] [Abstract][Full Text] [Related]
9. Validation study of the prototype of a disease-specific index measure for health-related quality of life in dementia.
Schölzel-Dorenbos CJ; Arons AM; Wammes JJ; Rikkert MG; Krabbe PF
Health Qual Life Outcomes; 2012 Sep; 10():118. PubMed ID: 23009579
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the sensitivity of EQ-5D in a sample of patients with type 2 diabetes mellitus in two tertiary health care facilities in Nigeria.
Ekwunife OI; Ezenduka CC; Uzoma BE
BMC Res Notes; 2016 Jan; 9():24. PubMed ID: 26758272
[TBL] [Abstract][Full Text] [Related]
11. The discriminative power of the EuroQol visual analog scale is sensitive to survey language in Singapore.
Luo N; Cang SQ; Quah HM; How CH; Tay EG
Health Qual Life Outcomes; 2012 Mar; 10():32. PubMed ID: 22429829
[TBL] [Abstract][Full Text] [Related]
12. Validation and reliability of the Chichewa translation of the EQ-5D quality of life questionnaire in adults with orthopaedic injuries in Malawi.
Chokotho L; Mkandawire N; Conway D; Wu HH; Shearer DD; Hallan G; Gjertsen JE; Young S; Lau BC
Malawi Med J; 2017 Jun; 29(2):84-88. PubMed ID: 28955412
[TBL] [Abstract][Full Text] [Related]
13. Psychometric properties of the EuroQol Five Dimensional Questionnaire (EQ-5D-3L) in caregivers of autistic children.
Khanna R; Jariwala K; Bentley JP
Qual Life Res; 2013 Dec; 22(10):2909-20. PubMed ID: 23615959
[TBL] [Abstract][Full Text] [Related]
14. Cross-cultural adaptation and validation of the Korean version of the EQ-5D in patients with rheumatic diseases.
Kim MH; Cho YS; Uhm WS; Kim S; Bae SC
Qual Life Res; 2005 Jun; 14(5):1401-6. PubMed ID: 16047514
[TBL] [Abstract][Full Text] [Related]
15. The validity of the EQ-5D-3L items: an investigation with type 2 diabetes patients from six European countries.
Konerding U; Elkhuizen SG; Faubel R; Forte P; Malmström T; Pavi E; Janssen MF
Health Qual Life Outcomes; 2014 Dec; 12():181. PubMed ID: 25479769
[TBL] [Abstract][Full Text] [Related]
16. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages?
Rutten-van Mölken MP; Oostenbrink JB; Tashkin DP; Burkhart D; Monz BU
Chest; 2006 Oct; 130(4):1117-28. PubMed ID: 17035446
[TBL] [Abstract][Full Text] [Related]
17. Utility of EQ-5D to assess patients undergoing cataract surgery.
Ang M; Fenwick E; Wong TY; Lamoureux E; Luo N
Optom Vis Sci; 2013 Aug; 90(8):861-6. PubMed ID: 23851304
[TBL] [Abstract][Full Text] [Related]
18. How does the EQ-5D perform when measuring quality of life in dementia against two other dementia-specific outcome measures?
Aguirre E; Kang S; Hoare Z; Edwards RT; Orrell M
Qual Life Res; 2016 Jan; 25(1):45-9. PubMed ID: 26163146
[TBL] [Abstract][Full Text] [Related]
19. Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients.
Pattanaphesaj J; Thavorncharoensap M
Health Qual Life Outcomes; 2015 Feb; 13():14. PubMed ID: 25890017
[TBL] [Abstract][Full Text] [Related]
20. Validity, reliability, and responsiveness of the EQ-5D in inflammatory bowel disease in Germany.
Stark RG; Reitmeir P; Leidl R; König HH
Inflamm Bowel Dis; 2010 Jan; 16(1):42-51. PubMed ID: 19475674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
